Method of promoting angiogenesis using relaxin
US6211147A · kind A · utility
28Cited by
9References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 15, 1996 |
| Grant date | Apr 3, 2001 |
| Priority date | — |
| Expiry date | Aug 15, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Relaxin is useful for promoting angiogenesis and the treatment of infections or ischemic wounds where the injury results from lack of oxygen due to poor circulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.